Pfizer Tej zaum Yuav Muaj Omicron-Optimized Covid Tshuaj Tiv Thaiv Npaj Los Ntawm Lub Caij Nplooj Ntoos Zeeg, CEO Hais

Tojsiab

Pfizer thiab BioNTech tuaj yeem ua tiav kev ua haujlwm los ntawm lub caij nplooj zeeg ntawm tus qauv tshiab ntawm nws cov tshuaj tiv thaiv Covid-19 uas tuaj yeem tiv thaiv tau zoo dua ntawm omicron variant thaum tseem muaj txiaj ntsig zoo rau lwm hom kab mob uas paub txog tus kab mob, Pfizer CEO Albert Bourla tau hais rau hnub Wednesday, raws li subvariants ntawm lub Cov kab mob kis tau zoo heev nyob rau hauv nruab nrab ntawm lub lull hauv Covid-txog cov neeg tuag.

Cov Lus Tseem Ceeb

Bourla tau hais hauv xov xwm Lus qhia tuav los ntawm International Federation of Pharmaceutical Manufacturers & Cov koom haum hais tias nws yog "muaj peev xwm," txawm hais tias tsis yog qhov tseeb tias kev txhaj tshuaj tuaj yeem npaj tau thaum lub caij nplooj zeeg, vim tias lub tuam txhab tseem khaws cov ntaub ntawv.

Pfizer tseem tab tom ua haujlwm los txuas ntxiv qhov ua tau zoo ntawm nws cov tshuaj tiv thaiv Covid-19 mus rau ib xyoos, piv rau cov kev txhaj tshuaj tam sim no uas tau pom tias ploj mus tom qab txog rau lub hlis, txawm hais tias Bourla tau hais tias nws tau "nyuaj heev."

Tus Keeb Kwm Tseem Ceeb

Cov tshuaj tiv thaiv Covid-19 tau tsim tawm tsam thawj tus qauv ntawm SARS-CoV-2 tus kabmob coronavirus tau pom tias tsis muaj txiaj ntsig zoo rau nws cov omicron variant, tshwj xeeb tshaj yog tom qab li rau lub hlis, kev tshawb fawb pom, suav nrog lub Peb Hlis. txoj kev tshawb no luam tawm nyob rau hauv New England Journal of Medicine. Kev tiv thaiv cov tsos mob tshwm sim los ntawm ib ncig ntawm 75% ob mus rau plaub lub lis piam tom qab koob thib ob mus txog 15% kwv yees li rau lub hlis tom qab.

Dab Tsi Los Saib

Niaj hnub pib theem 2 kev sim ntawm nws cov tshuaj Omicron tshwj xeeb tshuaj tua kab mob lub hli tas los. Nws tau tsim los tswj hwm tsawg kawg peb lub hlis tom qab pib txhaj tshuaj thib ob thiab koob thib peb los ntawm cov tshuaj tiv thaiv mRNA Covid. Lub tuam txhab tau hais tias nws lub hom phiaj los qhia nws cov kev tshawb pom nrog rau tsoomfwv saib xyuas kev noj qab haus huv "raws li lawv npaj rau lub caij nplooj zeeg lub caij nplooj zeeg."

Dab Tsi Peb Tsis Paub

Cov neeg tuag los ntawm Covid-19 thoob ntiaj teb tau poob rau lub lim tiam dhau los mus rau qib qis tshaj txij li hnub pib ntawm kev sib kis, Lub Koom Haum Saib Xyuas Kev Noj Qab Haus Huv Ntiaj Teb sau tseg Hnub Wednesday, txawm hais tias nws tau ceeb toom tawm tsam cov hloov pauv tshiab ntawm cov kab mob omicron uas tau ua rau muaj kev sib kis loj hauv qee lub tebchaws. Cov subvariants no, hu ua BA.2, BA.4 thiab BA.5, zoo li tsis muaj mob hnyav lossis kis tau zoo dua li cov kab mob omicron qub, txawm hais tias qhov kev poob qis tseem ceeb hauv kev sim rau Covid-19 tau txwv lub koom haum lub peev xwm los saib xyuas. cov subvariants no, WHO tau hais.

Pab them tag nrho thiab qhia txog cov Coronavirus

Tau qhov twg los: https://www.forbes.com/sites/masonbissada/2022/04/13/pfizer-may-have-omicron-optimized-covid-vaccine-ready-by-fall-ceo-says/